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http://dx.doi.org/10.10Although mTBI sustained in both military and civilian settings are likely to be underreported,
the combat theater presents additional obstacles to reporting and accessing care. The impact of
blast forces on the nervous system may differ from nonblast mechanisms, mTBI although
studies comparing the neurologic and cognitive sequelae in mTBI survivors have not provided
such evidence. However, emotional distress appears to figure prominently in symptoms
following military mTBI. This review evaluates the extant literature with an eye towards future
research directions.
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Traumatic brain injury (TBI) is a frequent source of
morbidity and mortality in both the civilian and military
populations. Hyder and colleagues [1] estimated the global
incidence of TBI at 10 million cases annually, with 1.7
million emergency department visits yearly among U.S. ci-
vilians [2]. Because these rates do not include injuries cared
for in military or Veterans Affairs (VA) hospitals, outpatient
clinics, doctor’s offices, or at home, it is probable they under-
estimate the true incidence of TBI [3].
In a military combat setting, the incidence of TBI is likely
to be higher. Hoge and colleagues [4] surveyed two Operation
Iraqi Freedom (OIF) Army combat brigades with validated
clinical instruments, generating 2525 surveys with usable
data. Approximately 15% of respondents had sustained a
TBI with either loss of consciousness (LOC) (4.9%) or altered
mental status (10.3%). Terrio and colleagues [5] screened anccess article under the CC BY-NC-ND license (http://
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16/j.jalz.2014.04.012OIF Army combat brigade (n 5 3973) and clinically evalu-
ated those reporting injury. Clinician-confirmed brain in-
juries, most in the mild range, were found in 22.8% (n 5
907) of the total sample. Similarly, Schell and Marshall’s
[6] work suggested incidence rates of 19.5% (upper limit es-
timate, 22.7%) among personnel serving in either Operation
Enduring Freedom (OEF) (Afghanistan) or OIF, based on
questionnaires administered upon return from deployment.
There is a paucity of data on the prevalence of chronic
TBI with persisting symptoms, and little information avail-
able on individuals who sustain multiple TBIs. A recent
study of military conscripts in Sweden [7] used the national
patient registry and concluded that, of 811,622 men with a
mean age of 18 years at the time of conscription, 34,698 sus-
tained one mild TBI, 4569 sustained two mild TBIs but no
severe TBI, and 5982 sustained at least one severe TBI dur-
ing a mean follow-up of 33 years.
In both civilian and military populations, most (76%–
83%) injuries are classified as mild TBI (mTBI) [8,9]. The
identification and treatment of a moderate to severe brain
injury is more straightforward in many ways than a mild
injury because of the obvious objective findings and clear
history, which are usually documented in acute care
records. With mTBI, the signs of injury overlap with other
conditions, such as acute stress reaction, posttraumatice Alzheimer’s Association.
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coexist with mTBI. The lack of objective markers on
neuroimaging or laboratory evaluations can also lead to
delayed diagnosis and inappropriate disposition. As such,
this article focuses on mild brain injury.
We first review the conceptual history and current diag-
nostic criteria for mTBI, including both the injury event
and the postinjury sequelae. In the remainder of this article
we review elements specific to military brain injury.
2. Conceptual history and diagnosis of mTBI
2.1. Conceptual history
Frequently, the lack of objective findings from neurolog-
ical examination and computed tomography (CT) scans after
mild brain injury result in spurious conclusions about the na-
ture of persisting symptoms. Such symptoms are often
attributed to functional disorders or desire for secondary
gain, either conscious or unconscious. Recently, results
from advanced neuroimaging studies of brain abnormalities
after mTBI have revised this view, and raised concerns about
possible unreported or undetected mTBIs. These concerns
take on particular importance with the realization that pro-
fessional athletes and military service members commonly
experience multiple mTBIs during their careers, and a
much larger number of subconcussive blows to the head
that do not result in mTBI. Recent evidence [10,11] has
suggested that a subgroup of patients with multiple mTBIs
may experience progressive neurodegenerative symptoms
during subsequent years and decades.
Traditionally, the time course of brain injury has been
described as occurring throughout two phases: (1) a primary
or mechanical injury, which is a discrete injury event, fol-
lowed by (2) a secondary, longer duration injury related to
the activation of molecular and biochemical pathways orig-
inated by the primary event. The secondary injury was
initially believed to be limited to hours or days postinjury.
However, new findings indicate that the abnormal signaling
and inflammatory processes activated during the secondary
injury persist for much longer.
Historically, TBI has been classified into three broad
mechanism categories: focal, diffuse, or mixed. Focal in-
juries emanate from blows to the head (e.g., assault with a
weapon, hit from another player’s helmet, striking an object
or the ground during a fall) that may involve direct impact of
the brain’s surface on the bony protuberances of the skull.
Focal mechanisms can result in laceration, contusion, and
hemorrhage. A special type of focal injury termed a coupe
contracoupe injury occurs when the head accelerates in one
direction striking an object (e.g., windshield), which in turn
propels the head in the opposite direction, striking another
object (e.g., headrest). Coupe contracoupe injuries are com-
mon in motor vehicle accidents.
Diffuse injury refers to the stretching and twisting of
axons and blood vessels by shear forces resulting from accel-
eration, deceleration, and rotation of the brain. Primary ax-otomy is rare during the initial mechanical insult and
usually occurs during the secondary injury phase. The im-
mersion in cerebrospinal fluid and attachment to the spinal
cord render the brain vulnerable to centrifugal motion on ac-
celeration and deceleration (e.g., falls) that can also occur
during focal injuries.
The mixed mechanism simply refers to the involvement
of both focal and diffuse mechanisms in a brain injury.
Both blast and nonblast brain injuries commonly involve
mixed mechanisms.2.2. Diagnosis of mTBI
2.2.1. The injury
Chief among the diagnostic challenges presented by
mTBI are heavy reliance on patient self-report or witness ac-
counts. Loss or alteration of consciousness and posttrau-
matic amnesia are inherent features of mTBI, and in the
absence of eyewitnesses, ascertainment of duration of
reduced consciousness is imprecise. The cognitive and
emotional difficulties that can result from TBI may also
reduce awareness and interfere with reliability of self-
report [12]. Last, symptoms resulting from mTBI, such as
headache, dizziness, depression, and anxiety, are nonspecific
and, although frequently exacerbated by injury, are also
common premorbidly (in the population at large). These fac-
tors underscore the need for objective measures that would
improve diagnostic accuracy and provide a substrate for
monitoring treatment.
Although based largely on self-reported information, the
basic definition and severity indicators for TBI have general
conceptual agreement among a broad array of institutions,
both civilian and military. However, the diagnostic criteria
for determining whether an mTBI has occurred is separate
from the criteria for diagnosing persisting symptoms attrib-
uted to such an event (e.g., postconcussion syndrome). Hoge
and colleagues [13] noted that the Department of Defense
(DOD) and the Department of Veterans Affairs (DVA) post-
deployment health care initiatives were more focused on
injury event determination than on current symptoms and
level of impairment. These investigators asserted that a uni-
tary definition for TBI—including symptoms, time course,
and level of impairment in addition to the injury event
criteria—would improve the utility of diagnosis.
Several professional societies and federal agencies have
developed diagnostic criteria for TBI, ascribing to some
version of disruption of brain function by an external force.
However, for the purposes of coding and remuneration,
numerous diagnostic codes have emerged to cover the
wide range of specific insults that can be involved in the
injury event. In medical settings, any of several hundred co-
des from the International Classification of Diseases, ninth
revision, Clinical Modification (ICD-9-CM) [14] can indi-
cate a head injury.
The high incidence of multiple mTBIs in military veter-
ans of combat theaters, and the accumulating evidence that
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the DOD and to adopt a common definition, and to develop
screening criteria and practice guidelines. In May 2007 [15],
the DOD and DVA agreed jointly to an adaptation of Amer-
ican Congress of Rehabilitation Medicine [16] definition of
brain injury as follows: “Any traumatically induced struc-
tural injury and/or physiological disruption of brain function
as a result of an external force that is indicated by new onset
or worsening of at least one of the following clinical signs,
immediately following the event:
1. Any period of loss of or a decreased level of con-
sciousness
2. Any loss of memory for events immediately before or
after the injury
3. Any alteration in mental state at the time of the injury
(e.g., confusion, disorientation, slowed thinking)
4. Neurological deficits (e.g., weakness, balance distur-
bance, praxis, paresis/paraplegia, change in vision,
other sensory alterations, aphasia) that may or may
not be transient
5. Intracranial lesion00 [15]
In addition, the DOD/DVA formalized their consensus-
based criteria for severity determinations [15] for closed
head injury (Table 1).
Several concerns about these criteria relate to specificity
and timing. The type of neuroimaging used (CT vs. magnetic
resonance imaging [MRI]) is not specified, nor is any guid-
ance on the timing. CT scans, frequently used in emergency
rooms, are generally less sensitive than MRI. The timing of
neuroimaging is another important issue; early signs of
injury can resolve within days, in both CTand MRI. Specific
guidance is also not provided for classification of patients
when indicators place them in different severity categories
(e.g., patients who experience only a few minutes of LOC
but report posttraumatic amnesia of several days).
2.2.2. Postinjury diagnostics
Symptoms after brain injury are frequently categorized
by their timing during the recovery period as either acute
or persisting, following the general template for phases of
recovery: acute, subacute, or chronic. Most symptoms are
present for just days or, at most, weeks after mild brain
injury. The operational definitions of these time periods,
particularly acute and subacute, differ from study to study.Table 1
DOD/DVA Consensus-based Classification of Closed TBI Severity [15].
Severity index Mild Modera
Neuroimaging findings Normal structural imaging Normal
Initial Glasgow Coma Scale score, pt 13–15 9–12
Duration of loss of consciousness 0–30 min .30 m
Duration of AOC A moment up to 24 h AOC .
Duration of posttraumatic amnesia, days 0–1 day .1 and
Abbreviation: AOC, alteration of consciousness.However, the outer limits of the chronic period are gener-
ally considered to begin 3 to 6 months postinjury.
Although idiographic variations are the rule in recovery
timing, 3 months has been viewed traditionally as the
outer limit of the time period in which the brain repairs
itself from mild brain injury (the natural recovery period)
[15].
Once thought to be a rare occurrence, a substantial num-
ber of military personnel and veterans report symptoms from
mild brain injury persisting long after the 3-monthmark. The
prevalence of persisting symptoms appears to range from
20% to 48% in veterans [17]. In civilian mTBI, evidence
[18] suggests that persisting symptoms are present in only
3% to 5%. As discussed later, persisting (chronic period)
symptoms in veterans and military personnel have been
linked to both mTBI and coexisting mental health condi-
tions.
The set of symptoms that can follow and persist after
mTBI are defined differently by the ICD-9-CM and the
Diagnostic and Statistical Manual for Mental Disorders,
fourth edition, Text Revision (DSM-IV-TR)[19]. The ICD-
9-CM criteria include a history of mTBI and the presence
of three or more of the following eight symptoms: (1)
headache, (2) dizziness, (3) fatigue, (4) irritability, (5)
insomnia, (6) concentration or (7) memory difficulty, and
(8) intolerance of stress, emotion, or alcohol. However the
DSM-IV-TR, criteria require evidence of attention or mem-
ory difficulty from quantifiable cognitive evaluation. One
of the limitations of both sets of diagnostic criteria is their
focus on symptoms and signs and exclusion of
mechanism-based information [20].3. Military TBI
3.1. Combat theater factors
Military TBI (TBI occurring during deployment to a
combat zone) differs from civilian brain injury in several
important ways. Although the incidence of TBI, particularly
mild injuries, are believed to be underreported in both the
military and civilian populations, the unique nature of the
combat theater presents additional obstacles to reporting, ac-
cessing care for, and documenting such injuries [3,21].
Tanielian and Jaycox’s findings suggested “poor
documentation of blast exposures and failure to identify
individuals with probable TBI” [21, p. xxvi].te Severe
or abnormal structural imaging Normal or abnormal structural imaging
,9
in and ,24 h .24 h
24 h (use other criteria)
,7 .7
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frequently embedded in longer, continuous missions rather
than occurring as discrete events, as is often the case in
civilian brain injury (e.g., motor vehicle accidents, falls,
and so on). Removing oneself from active combat to report
mild injury or to access care often does not occur.
Military service members who experience TBIs are
frequently sleep deprived and operating under high levels
of physiological stress and emotional trauma. The stress
and ongoing sensory experience of the combat environment
can impede the ability to identify or recognize postinjury
symptoms significantly and can interfere with the encoding
of details for future recall. These factors may also diminish
resilience and reduce the ability to recover from seemingly
mild injuries.
Comorbid mental health symptoms and conditions are
more prevalent in those who experienced a military mTBI
compared with their civilian counterparts. Such symptoms
are difficult to differentiate from mTBI sequelae. Like
many of its comorbidities, mTBI relies upon patient self-
report for diagnosis, limiting diagnostic accuracy [22].
A disproportionate fraction of military TBIs are associ-
ated with high-energy explosions, which may impact the
brain in novel ways. Multiple mTBIs are common in combat
settings, and multiple deployments are often the rule during
a prolonged conflict [23,24]. Repeated mTBIs and/or
exposures to subconcussive blasts increase concern about
vulnerabilities with aging and emerging neurodegeneration
or chronic traumatic encephalopathy (CTE).3.2. Blast vs. nonblast TBI
Both nonblast- and blast-related brain injuries are hetero-
geneous in their mechanism. DePalma and colleagues [25]
reported a conceptual schematic of blast-related brain injury
mechanisms, which when combined, include the potential
for any number of focal and diffuse cerebral injuries. For
example, the primary blast mechanism refers to the over-
pressurization shock wave associated with high-energy ex-
plosives. Additional insults can result from secondary
(flying debris) or tertiary (body displacement) mechanisms.
Crush injuries from structure collapse and burns are classi-
fied as quaternary mechanisms.
Given the forces present in the overpressurization shock
waves that emanate from high-energy explosives, which
can travel at the speed of sound with the potential to be
multiplied by reflection [26], it has been hypothesized that
the damage from this mechanism may differ substantially
from that of nonblast origin. However, in its natural state,
this mechanism is highly complex, with multiple mediating
and moderating variables that have presented challenges to
experimental modeling.
The very method of transmission through which the blast
contributes to brain injury is currently a topic of vigorous
debate. Proposed transmission modes have included direct
neural transmission [27], vascular propagation [26] and,more recently, acceleration/deceleration of the head [11].
Although acceleration/deceleration also occurs frequently
in nonblast TBI, the velocity is likely significantly greater
during a blast.
Despite the inherent logic of greater acceleration/
deceleration velocity as a critical difference between blast
and nonblast mechanisms, the few studies completed to
date have not found consistent evidence that blast and
nonblast mTBI sequelae differ substantially. These studies
have examined neuroimaging metrics, neuropsychological
performance, and self-reported symptoms that are ac-
counted for by blast and nonblast mechanisms. This
research is confounded by the very low incidence of iso-
lated primary blast. With vanishingly rare exceptions, ser-
vice members who report mTBI associated with a blast
exposure also report secondary or tertiary injury mecha-
nisms.
Very few neuroimaging studies have compared blast and
nonblast mTBI directly. Davenport and colleagues [28]
executed a diffusion imaging study that hypothesized
blast-related mTBI would be associated with subtle axonal
damage that was spatially disparate between individuals.
Compared with nonblast, blast mTBI was related to a greater
number of voxels with low fractional anisotropy in hypoth-
esized tracts and across the white matter mask. An interac-
tion effect showed that the presence of a prior nonblast
mTBI was only associated with a greater number of these
voxels in the absence of blast mTBI.
Several investigators have examined differences in these
mechanisms through performance on neuropsychological
tests. Belanger [29] found an absence of main effects be-
tween those with mild or moderate-to-severe blast-related
TBI compared with individuals with the same severity levels
from the nonblast group. Cognitive domains tested included
speed/flexibility and verbal and visual learning and memory.
An interaction effect for visual memory showed stronger
performance in those with blast-related mTBI and poorer
performance for those with blast-related moderate-to-severe
TBI vs. same-severity non-blast TBI groups.
Lange and colleagues [17] reported an absence of neuro-
psychological differences between a group with blast-
related mTBI plus secondary blunt trauma (n 5 35)
compared with a nonblast blunt trauma group (n5 21) after
controlling for depression and stress. These groups showed
no differences on the clinical scales of the Personality
Assessment Inventory.
Several investigative groups have conducted high-quality
record reviews or surveys comparing differences in persist-
ing symptoms between those sustaining blast and nonblast
mTBIs. Wilk and colleagues [30] surveyed 3952 U.S.
Army personnel several months after returning from OIF.
Five hundred eighty-seven soldiers (14.9%) had self-
reported concussion, 201 with LOC (34.2%) and 373 with
alteration of consciousness (63.5%). Four hundred twenty-
four (72.2%) reported the mTBI as blast related and 150
(25.6%) as nonblast related. The blast mechanism was
J.C. Chapman and R. Diaz-Arrastia / Alzheimer’s & Dementia 10 (2014) S97-S104 S101associated with headaches and tinnitus, but only for those
with LOC. However, among the entire concussion group,
the blast mechanism was not related to mental or physical
health outcomes. Nonblast mTBI was associated signifi-
cantly with self-reported concentration and memory prob-
lems, and abdominal symptoms.
Lippa and colleagues [31] examined postconcussive
symptoms and PTSD scores in the medical records of 339
OEF/OIF veterans with mTBI. Veteran scores on the Neuro-
behavioral Symptom Inventory (NSI) [32] and the Posttrau-
matic Stress Disorder Checklist (PCL) [33] were analyzed
by type of mTBI: (1) blast related only (n 5 148), (2) non-
blast related only (n 5 56), or (3) both, having sustained at
least one blast-related mTBI and one nonblast-related
mTBI (n 5 145). The two blast-related mTBI groups were
younger and had more PTSD symptoms than the nonblast
group. However, no differences were found among these
groups for severity of postconcussive symptoms. Neither
the number of blast-related mTBIs nor the estimated dis-
tance from the blast was related statistically to postconcus-
sive symptoms. PCL scores accounted for a greater
amount of unique variance (46.6%, P 5 .001) in the total
postconcussive symptoms than LOC (1.6%, P 5 .02). It
should be noted that, as a result of the fact that blast-
related mTBI includes both blast and nonblast mechanisms
in the great majority of cases [34], the blast-only group likely
did not differ from the both blast and nonblast group.
Belanger and colleagues [35] compared self-reported
symptoms on the NSI and PCL between clinician-
diagnosed blast (n 5 292) and nonblast (n 5 92) mTBI
groups. Results showed that neither mechanism of injury
(blast vs. nonblast) nor type of reduced consciousness
(LOC versus alteration of consciousness) accounted for sig-
nificance amounts of variance in total NSI symptom scores.
Greater symptoms were reported by those injured more than
1 month ago (compared with less than 1 month) and by those
endorsing more PTSD symptoms. Hearing difficulty was the
only individual symptom that differed between groups.
Overall, these results suggest an integral role for
emotional distress in persisting symptoms from military
mTBI, whether from blast or nonblast mechanisms. Howev-
er, several other factors must also be considered. First,
although insignificant in one of the previously mentioned
studies, basic physics dictates that, in high-energy explo-
sions, distance from detonation is a key, but frequently inde-
terminate, factor in the assessment of brain injury presence.
In addition, rather than a graduated dose effect between mild
vs. moderate-to-severe blast TBI, the blast mechanism may
operate through a threshold effect, with symptomatic differ-
ences in mechanism emerging with moderate injuries that
are more proximal to the point of detonation. Other factors
may mediate or moderate blast TBI in ways that are not
currently understood. Few blasts occur in the open field,
on which older models are based.
Second, if emotional factors are the primary etiology for
postconcussive symptoms, then we should expect this samesymptom set in many individuals with PTSD from trauma ex-
posures with features similar to those experienced in combat.
Evaluation of multiple study groups such as the military units
described here would help to identify and rank candidate fea-
tures (e.g., traumas with long duration, with persistent or
semipersistent stressors, occurring in unfamiliar surround-
ings, and so on) associated with combat PTSD. An investiga-
tion of individuals with civilian PTSD from analog stressor
experiences could produce informative convergent or diver-
gent validity with respect to the presence of postconcussive
symptoms and whether they are accounted for by PTSD
symptoms.
Third, many of the aforementioned studies used self-
report measures. Although self-report is an important element
in the diagnostic process, human judgment and memory are
subject to certain limitations and individual perceptions.
For example, although neural changes after blast-related
mTBI may impact functioning negatively, they may be expe-
rienced and/or reported in ways inconsistent with their origin.
The most salient feature to an individual may be the fear that
he/she feels rather than the subtle cognitive difficulties result-
ing in that fear. In this way, self-report instruments capture
only the variance related to symptoms that are foremost in
the mind of the reporter. Indeed, outcomes research in recent
years has prioritized “patient-related outcomes” over “dis-
ease-related outcomes”—meaning, the experience of the pa-
tient is of primary importance. Although this view should not
be discounted, it also should not be left unchecked by objec-
tive data, given the abundant evidence of the limitations of the
former. The careful integration of objective and subjective
data is likely to produce ground truth. Furthermore, such inte-
grative solutions may be possible only through machine
learning strategies.
Last, as discussed in the following sections, symptoms
of physiological or emotional stress associated with expo-
sure to combat can be highly variable within the same in-
dividual, emerging and submerging in an idiographic
pattern, and presenting challenges in measurement and
interpretation. Substantial and meticulous work must
ensue before conclusions can be drawn about blast vs. non-
blast mechanisms.3.3. Psychiatric comorbidities
Psychiatric and substance-abuse related conditions occur
frequently with military brain injury. An archival study [36]
of 12,056 OEF/OIF veterans diagnosed with deployment-
related brain injury through the DVA standardized diag-
nostic procedure, the Comprehensive TBI Evaluation,
examined patient records for psychiatric diagnoses and neu-
robehavioral symptoms. PTSD or a depressive disorder was
found in 67% and 34% of this sample, respectively, with
29% having both. Thirty-four percent had been diagnosed
with alcohol- (26%) or drug-related (8%) conditions.
Attribution of symptoms after mTBI to brain injury vs.
other frequently comorbid conditions such as PTSD and
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these conditions relies heavily on patient self-report of
events and symptoms, limiting diagnostic accuracy. In the
case of mental health conditions, the potential reluctance
to discuss painful or stigmatizing details can impede accu-
racy [22,39,40]. In addition, the shared symptoms between
mTBI, PTSD [12], and depression complicate differential
diagnosis further.
Exposure to emotional trauma is more likely in the combat
theater, as is the development of PTSD.AmongU.S. civilians,
approximately 61% of men and 51% of women will be
exposed to trauma during their lifetime, but only about 8%
(5% of men and 10% of women) will develop PTSD, based
on the National Comorbidity Survey [41]. As would be ex-
pected, PTSD occurs more frequently among military
personnel deployed to combat zones than within the civilian
population. The general stress of deployment combined
with the greater incidence of trauma exposure likely accounts
for these higher rates. PTSD prevalence for those serving in
OEF and OIF has been estimated at 14% [6]. These investiga-
tors also found that fully one-third of OEF/OIF veterans with
probable TBI also had probable PTSD. A review by Carlson
and colleagues [42] reported that, although comorbidity rates
for mTBI and PTSD among military personnel vary widely
(0%–89%), the largest studies cited figures between 33%
and 39%. In contrast, the largest civilian studies of mTBI
showed that PTSD comorbidity ranged from 12% to 27%.
Despite the association of PTSD with physical or post-
concussive symptoms in some studies comparing blast vs.
nonblast mechanisms, other studies have found that having
both diagnoses accounts for greater variance in persisting
symptoms than either condition alone. Brenner and col-
leagues [43] conducted a retrospective analysis of the sam-
ple reported on by Terrio and colleagues [5]. The injured
soldiers (n 5 1247) from a combat brigade included 907
with one or more clinician-confirmed TBIs and 385 with
other injuries (not TBI). After adjustments for demo-
graphics, having both mTBI and PTSD was related more
strongly to postconcussive symptoms (adjusted preva-
lence, 6.27) than either mTBI (adjusted prevalence, 4.03)
or PTSD (adjusted prevalence, 2.74) alone.
The same factors creating challenges in diagnosis of
mTBI are encountered again in treatment. Decisions related
to the timing and monitoring of treatments and transitions
are complicated by the absence of objective markers. Evi-
dence linking PTSD and chronic stress to cardiovascular dis-
ease and dementia has accumulated [22] in tandem with
findings linking multiple concussions to CTE [10].4. Chronic traumatic encephalopathy
CTE, formerly called “punch drunk” or “dementia pugi-
listica,” was first described by Dr. Harrison Martland [44] in
a 1928 article discussing the punch drunk state of many
retired boxers. The condition was termed “dementia pugilis-
tica” by Millspaugh [45] in 1937, and “chronic progressiveencephalopathy of the boxer” by Critchley [46]. In 1973,
Corsellis and colleagues [47] described three stages of
symptoms that appeared to typify the degeneration associ-
ated with CTE. Affective and psychotic symptoms charac-
terized the first stage. The second stage comprised social
volatility, memory loss, unpredictable behavior, and the
early presentation of Parkinson’s disease. The third stage
was marked by cognitive changes leading to dementia, gait
disorders, and, in many cases, advanced parkinsonism.
Although originally described in boxers, other contact
sports have been implicated in CTE as well. After a number
of professional football players retired early as a result of
postconcussion syndrome, the National Football League
created the National Football League Committee on Mild
Traumatic Brain Injury in 1994. In a recent article, McKee
and colleagues [10] reported results from the postmortem
pathological examinations of 85 cases with a history of repet-
itive mTBIs and 18 control subjects without such history. The
cases included 64 athletes and 21 military veterans. Of the 21
veterans, many (n 5 16) were athletes and only four were
exposed to a blast. McKee and colleagues [10] found CTE
in 68 of the 85 cases and in zero of the control subjects.
This investigation was not designed to address incidence of
CTE and, at this time, such estimates are unknown. Incidence
can only be estimated with prospective longitudinal studies.
It is hypothesized that CTE can be comorbid with other
neurodegenerative conditions such as Alzheimer’s disease,
Lewy body disease, frontotemporal dementia, or motor
neuron disease [39,40,48–50]. However, as McKee and
colleagues [10] noted, CTE appears distinguishable patho-
logically from other neurodegenerative diseases, especially
with respect to topographical dispersion and, to a lesser de-
gree, type of pathological entity (although see Hong and col-
leagues [51]) and course (e.g., slower rate of progression
through stages [10]). In addition, although CTE often begins
with clinical symptoms of behavior and personality changes
similar to frontotemporal dementia, the timing of psychiatric
symptoms differs significantly from the more prevalent Alz-
heimer’s disease.
From the close assessment of the studied cases, McKee
and colleagues [10] refined earlier pathological and clinical
characterization of CTE stages. Clinical characterization
was completed by interview with family and review of med-
ical records. Specifically, McKee and colleagues [10] detail
four stages. During stage I, multifocal and frequently peri-
vascular axonal varicosities are found in the frontal cortex,
subcortical white matter, and deep fiber tracks in the dien-
cephalon. The most common clinical symptoms in stage I
include headache and loss of attention/concentration. Dur-
ing stage II, axonal disruptions extended to the temporal
cortices, and the clinical symptoms added, are mood
swings/depression, explosive episodes, and short-termmem-
ory loss. During stage III, macroscopic findings include mild
atrophy, abnormalities of the septum, lateral and third
ventricle dilation, and mild to moderate depigmentation of
the locus coeruleus and substantia nigra. Axonal loss and
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are found in the subcortical white matter, particularly in the
frontal and temporal cortices. Clinical symptoms include
cognitive impairment with memory loss, executive dysfunc-
tion, loss of attention/concentration, depression, explosivity,
and visuospatial deficits. Last, stage IV is described as a pro-
gression of macroscopic findings, diffuse and marked axonal
loss, and distortion found in the subcortical white matter.
Clinical symptoms extended from stage III to frank demen-
tia, with some cases displaying paranoia and impulsivity.
Within McKee and colleagues’ [10] cohort with patho-
logically confirmed CTE, 11% were asymptomatic, with
many of these cases in stage II at death. As they note, this
finding raises the possibility that, in some affected persons,
CTE may not produce symptoms, or that CTE may not prog-
ress. In addition, data from McKee [10] and Goldstein [11]
suggested that CTE can occur after a single TBI of mild or
greater severity. Taken together, these results heighten the
imperative to conduct careful and thorough prospective, lon-
gitudinal investigations of TBI.
5. Conclusion
Based on our review of the military mTBI literature,
several important themes emerge. First, a large body of ev-
idence indicates that there are important differences be-
tween civilian and military TBI. Second, the important
role of emotional distress after military mTBI must be
incorporated into study designs and treatment approaches.
Third, attempts should be made to determine the roles asso-
ciated with dose and threshold effects for the blast mecha-
nism of TBI. Fourth, analogs of combat PTSD could be
identified and tested for the presence of postconcussive
symptoms and whether they can be accounted for by
PTSD. This type of study would inform the importance of
the mTBI component. Fifth, the amalgam of symptoms
emanating from OEF/OIF/Operation New Dawn (OND)
military personnel and veterans may represent an injury/
trauma syndrome. Sixth, objective and subjective measures
should be integrated in very large samples through machine
learning procedures. Based on the linkages among TBI,
PTSD, and neurodegenerative conditions, identification of
objective markers for receding, persisting, and emerging
symptoms is critical. Treatment approaches should be based
upon the results of these inquiries.
We have reported previously on the links among TBI,
PTSD, Alzheimer’s Disease, and other dementias [52].
This special issue updates the evidence that links military
TBI to emerging symptoms.Acknowledgments
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